Traeger A, Stein G, Sperschneider H, Keil E
Int J Clin Pharmacol Ther Toxicol. 1984 Sep;22(9):481-6.
Three groups of patients with kidney diseases were investigated: I. creatinine in serum less than 100 mumol/l, II. creatinine in serum 100-250 mumol/l, III. creatinine in serum greater than 250 mumol/l. After intravenous injection of 40 mg and 80 mg furosemide, serum concentrations and urinary excretion of the unchanged drug were measured fluorometrically. Moreover, urinary excretion of water, electrolytes, creatinine and urea nitrogen were estimated in order to check the pharmacodynamic effect of the drug. The pharmacokinetic parameters calculated were similar in group I and II. In group III t 1/2 was prolonged, renal clearance of furosemide was diminished. The diuretic effect of furosemide was noticeable during the first 4 hours following the injection of 40 mg in all 3 groups. Doubling the dose did not enhance the effect. Creatinine and urea nitrogen excretion in urine were not influenced by furosemide.
第一组,血清肌酐低于100微摩尔/升;第二组,血清肌酐为100 - 250微摩尔/升;第三组,血清肌酐高于250微摩尔/升。静脉注射40毫克和80毫克呋塞米后,采用荧光法测定血清中未变化药物的浓度和尿排泄量。此外,估算了水、电解质、肌酐和尿素氮的尿排泄量,以检查该药物的药效学作用。计算得出的药代动力学参数在第一组和第二组中相似。在第三组中,t1/2延长,呋塞米的肾清除率降低。在所有三组中,注射40毫克呋塞米后的最初4小时内,其利尿作用明显。剂量加倍并未增强该作用。呋塞米对尿中肌酐和尿素氮的排泄没有影响。